Cargando…
Development and Application of a Patient Group Engagement Prioritization Tool for Use in Medical Product Development
INTRODUCTION: Patient group engagement is increasingly used to inform the design, conduct, and dissemination of clinical trials and other medical research activities. However, the priorities of industry sponsors and patient groups differ, and there is currently no framework to help these groups iden...
Autores principales: | Perry, Brian, Dombeck, Carrie, Smalley, Jaye Bea, Levitan, Bennett, Leventhal, David, Patrick-Lake, Bray, Brennan, Linda, McKenna, Kevin, Hallinan, Zachary, Corneli, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864807/ https://www.ncbi.nlm.nih.gov/pubmed/32996107 http://dx.doi.org/10.1007/s43441-020-00217-0 |
Ejemplares similares
-
Stakeholder Experiences with the Single IRB Review Process and Recommendations for Food and Drug Administration Guidance
por: Corneli, Amy, et al.
Publicado: (2021) -
Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials
por: Dombeck, Carrie B., et al.
Publicado: (2019) -
Stakeholders’ views on the most and least helpful aspects of the ICH E6 GCP guideline and their aspirations for the revision of ICH E6(R2)
por: Dombeck, Carrie, et al.
Publicado: (2022) -
Investigator Experiences Using Mobile Technologies in Clinical Research: Qualitative Descriptive Study
por: McKenna, Kevin Christopher, et al.
Publicado: (2021) -
More than a box to check: Research sponsor and clinical investigator perspectives on making GCP training relevant
por: Swezey, Teresa, et al.
Publicado: (2020)